INS and early-onset autosomal dominant Alzheimer disease: Even though insulin signaling in the CNS cannot be studied in living humans, brain slices taken post-mortem from patients with Alzheimer’s disease respond to ex vivo insulin stimulation (in terms of insulin receptor signaling phosphorylation), but not at the level of age-matched controls (Talbot et al., 2012).